Cited by 625Diabetes Management and ResearchDiabetes Treatment and ManagementClinical Laboratory Practices and Quality Control

Tests of glycemia in diabetes

Open access
Goldstein, David E., Little, Randie R., Lorenz, Rodney A., Malone, John I., Nathan, David, Peterson, Charles M., Sacks, David B.·2004·Diabetes Care

Abstract

National Glycohemoglobin Standardization Program; SMBG, self-monitoring of blood glucose; UKPDS, U.K. Prospective Diabetes Study.A table elsewhere in this issue shows conventional and Syste

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.7.1761

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acetoacetate and acetone may increase as beta-hydroxybutyrate falls during successful therapy of diabetic ketoacidosis.

    “since AcAc and acetone may increase as bOHB falls during successful therapy (295,298).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [295]

    The Urine ketone testing section says the relative proportions of β-hydroxybutyrate, acetoacetate, and acetone vary, and that urine ketones can persist during recovery from ketoacidosis after blood ketones fall. It does not say that acetoacetate and acetone may increase specifically as β-hydroxybutyrate falls during successful therapy; no page number is available in our copy. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • Concentrations of fructosamine and glycated albumin reflect mean glycemia over a shorter time (15 to 30 days) than glycated hemoglobin (60 to 90 days).

    “Concentrations of these glycated proteins also reflect mean glycemia but over a much shorter time (15 to 30 days, reflecting the turnover of albumin) than GHb ( 60 to 90 days) (295,(311)(312)(313)(314)(315)(316).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [295]

    The “Glycated serum proteins” section says that albumin’s shorter turnover makes glycated serum proteins an index of glycemia over a shorter period than glycated hemoglobin. It does not give the claimed 15–30-day and 60–90-day windows; the “Glycated hemoglobin testing” section instead describes GHb as providing a glycemic history of the previous 120 days. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Glycosylated hemoglobin reflects long-term glycemic control and is a more accurate and stable measure than fasting plasma glucose.

    “Glycosylated hemoglobin reflects long-term glycemic control and is a more accurate and stable measure than FPG levels [13,14].”

    From A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults (2015) · cites this paper as [13]

    The ‘Glycated hemoglobin testing’ and ‘Standardization of GHb’ sections describe glycosylated hemoglobin as a measure of glycemia over preceding weeks and months, supporting the long-term-control claim. The copy does not establish that it is more accurate or a more stable measure than fasting plasma glucose; its description of stable hemoglobin components does not make that comparison. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Glycosuria is normally evidenced when the renal reabsorption threshold is exceeded (>180 mg/dL), even if there is individual variability.

    “Glycosuria is normally evidenced when the renal reabsorption threshold is exceeded (>180 mg/dL), even if there is individual variability 171,172.”
  • The lack of precision and sensitivity of urine glucose test limits its use.

    “However, the lack of precision and sensitivity of this test limits its use 172”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. [3]3. Wilson JD, Foster DW, Eds. Philadelphia, Saunders, 1992, p. 1235-1333
  2. [6]6. Burtis C, Ashwood E, Eds. Philadelphia, Saunders, 1999, p. 750 -808
  3. [85]85. Goldstein DE, Little RR, Wiedmeyer HM, England JD, Rohlfing CL: Glycated haemoglobin estimation in the 1990's: a review of assay methods and clinical in- terpretation. In Diabetes Annual. Vol. 8. Marshall SM, Home PD, Eds. Amsterdam, Eslevier, 1994, p. 193-212
  4. [162]162. Ryall RG, Ed. Adelaide, Australia, The Organizing Committee: "Glycated Proteins in Diabetes Mellitus " Symposium 1988, 1990 177.
  5. [168]168. Ryall RG, Ed. Adelaide, Australia, The Organizing Committee: "Glycated Proteins in Dia- betes Mellitus" Symposium 1988, 1990 182.
  6. [169]169. Bach L, Goodall 1, Wirth A, Chapman J, Jerums G: A comparison of fruc- tosamine, HbA1c and home blood glu- cose monitoring in type 1 diabetics: glycated proteins in diabetes mellitus. In Proceedings of an International Sympo- sium, Adelaide, Australia.
  7. [170]170. Ryall RG, Ed. Adelaide, Australia, The Organizing Committee: "Glycated Proteins in Dia- betes Mellitus" Symposium 1988, 1990 183.

Cited by

Sorted by citations

Authors
Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., Nathan, D., Peterson, C. M., & Sacks, D. B.
Affiliations
  • University of Missouri (US)
  • Peoria campus of the University of Illinois System (US)
  • University of South Florida (US)
  • Massachusetts General Hospital (US)
  • National Heart, Lung, and Blood Institute (US)
  • Brigham and Women's Hospital (US)
Venue
Diabetes Care
Published
2004-07-01
Volume
27
Issue
7
Pages
1761-1773
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4295849207
Cited by
625
References
155
Citations by year
2026: 18 · 2025: 17 · 2024: 22 · 2023: 25 · 2022: 37 · 2021: 27 · 2020: 25 · 2019: 32 · 2018: 40 · 2017: 30 · 2016: 37 · 2015: 29 · 2014: 24 · 2013: 20 · 2012: 45
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
Keywords
glycemia, diabetes mellitus, HbA1c, HbA1c standardization, self-monitoring of blood glucose, glycemic control, UKPDS
MeSH terms
Blood Glucose, Diabetes Mellitus, Glycosuria, Humans, Ketones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review